Contract

Occupational Medicine Physician

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

No salary listed

Buc, France

In Person

MD

Category
Medical, Clinical & Veterinary (1)
Required Skills
First Aid

Get referred to GE Healthcare

See people who can refer or advise you

Requirements
  • A French State Diploma of Doctor of Medicine is required.
  • A specialization in occupational medicine, such as DES, CES, or an equivalent recognized in France, is required.
  • Valid authorization to practice medicine in France is required.
  • Confirmed experience in occupational health, ideally in an industrial or technology environment, is required.
  • Strong knowledge of French labor law and occupational-health regulations is required.
  • Knowledge of legal matters related to occupational health is required.
  • Fluency in French and a good professional level of English are required.
  • The role requires communication, interpersonal, and advisory skills, confidentiality, and high ethical standards.
  • The role requires demonstrated management and team-supervision skills in occupational health.
Responsibilities
  • Conduct mandatory medical examinations, including pre-employment, periodic, and return-to-work examinations.
  • Monitor employees’ health, including employees exposed to radiation or other occupational risks.
  • Assess employees’ fitness for specific positions and recommend accommodations when necessary.
  • Maintain accurate and confidential medical records.
  • Identify, prevent, and reduce occupational risks.
  • Contribute to improving working conditions and reducing work-related stress.
  • Participate in analyses of occupational accidents and diseases and contribute to prevention plans.
  • Contribute to managing occupational exposures.
  • Participate in health monitoring and trend analysis.
  • Advise management, employees, and their representatives on occupational-health matters.
  • Provide expertise on prevention measures, ergonomics, and workplace accommodations.
  • Collaborate with Human Resources and Environment, Health and Safety teams on health-related initiatives.
  • Participate in Social and Economic Committee meetings and bodies addressing psychosocial risks.
  • Contribute to multidisciplinary initiatives linking health, performance, and work.
  • Lead or participate in health-promotion and awareness campaigns.
  • Ensure compliance with French labor law and occupational-health regulations.
  • Stay informed about legal and professional developments in occupational health.
  • Align the occupational-health strategy with company objectives.
  • Participate in company emergency arrangements and provide first aid when necessary.
  • Contribute to business continuity through health-preparedness initiatives.
  • Supervise occupational-health nurses and delegated medical activities.
  • Maintain occupational-health service processes and procedures.
  • Lead occupational-health team meetings, ensure effective service operation, and align the service with business needs.
Desired Qualifications
  • A qualification in radiation protection, or willingness to obtain one after hiring, is preferred.
  • Experience in radiation medicine or monitoring occupational exposures is preferred.
  • Strong analytical and problem-solving abilities are preferred.
  • The ability to work effectively in a multidisciplinary environment is preferred.
  • A proactive approach to employee health promotion, prevention, and well-being is preferred.
  • Excellent listening skills and the ability to influence stakeholders at all levels are preferred.

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Photonova Spectra won CE Mark on August 31, 2026, opening Europe sales.
  • Q2 2026 orders rose 11.1%, with 1.15x book-to-bill and record backlog.
  • Vivid cardiovascular ultrasound and ABUS breast screening launches broaden 2026 revenue opportunities.

What critics are saying

  • Patient Care Solutions revenue fell 13.5% in Q2 2026; management is reviewing a sale.
  • Jay Saccaro left in August 2026; William Grogan starts September 14, 2026.
  • If PCS recovery slips into 2027, GE HealthCare becomes a slower-growth imaging vendor.

What makes GE Healthcare unique

  • Photonova Spectra’s Deep Silicon CT differentiates GE HealthCare with photon-counting imaging.
  • GE HealthCare spans imaging, pharma diagnostics, ultrasound, and monitoring across hospital workflows.
  • The July 2026 backlog of $23.9 billion reflects sticky installed-base demand and services.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

Yahoo Finance
Sep 1st, 2026
GE HealthCare secures CE mark for Photonova Spectra photon-counting CT system

GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.

Yahoo Finance
Aug 31st, 2026
Vertex Pharmaceuticals shows promise while GE HealthCare and Wells Fargo face challenges

Vertex Pharmaceuticals has emerged as a standout S&P 500 stock, according to StockStory's analysis. The company, which focuses on developing transformative medicines for serious diseases including cystic fibrosis and sickle cell disease, boasts a market capitalisation of $137.3 billion. Meanwhile, StockStory recommends avoiding two large-cap stocks. GE HealthCare, spun off from General Electric in 2023, faces concerns over stagnant organic revenue growth and declining operating margins. The medical equipment provider has a market cap of $32.4 billion. Wells Fargo also made the avoid list. The diversified financial services company, with a $262.2 billion market cap, has seen its net interest margin shrink by 33.6 basis points over two years, suggesting increased competition or declining loan profitability.

Associated Press
Aug 28th, 2026
GE HealthCare launches three new Vivid cardiovascular ultrasound systems for diverse care settings

GE HealthCare has introduced three new cardiovascular ultrasound systems to its Vivid portfolio: Vivid Explorer 1, Vivid Advanced 1, and Vivid Focus 1. The systems were unveiled at the European Society of Cardiology Congress 2026 in Munich, Germany. Each system targets different clinical settings whilst sharing a common technology foundation with the ultra-premium Vivid Pioneer. Vivid Explorer is designed for high-volume echo labs, Vivid Advanced for mid-size hospitals and cardiology practices, and Vivid Focus for everyday cardiac imaging. All three systems use cSound imaging technology and include AI-enabled automation tools to streamline echo workflows. The systems have received CE Mark approval but are awaiting US FDA 510(k) clearance and are not yet available for sale in the United States.

Yahoo Finance
Aug 3rd, 2026
GE HealthCare launches Invenia ABUS Prime and StreamVue for breast cancer screening

GE HealthCare has launched Invenia ABUS Prime and ABUS StreamVue, expanding its breast imaging portfolio with solutions for supplemental screening in women with dense breasts. The Invenia ABUS Prime system has been installed at BeSound in Los Angeles, marking one of the first US installations. ABUS StreamVue is a browser-based reading solution enabling remote exam review across imaging networks. The system received FDA 510(k) clearance and CE Marking. Studies show 40% of women have dense breasts, carrying four to six times higher breast cancer risk. Research indicates mammography may miss one-third of cancers in dense breasts. Invenia ABUS Prime features AI-enabled tools including Scan Quality Assessment and can increase scan speed by up to 40%. The AI Assistant has demonstrated a 33% reduction in reading time.

Yahoo Finance
Jul 29th, 2026
GE HealthCare Q2: Orders up 11%, backlog hits record $23.9B amid Patient Care struggles

GE HealthCare Technologies reported second-quarter results with orders rising 11% year-over-year and backlog reaching a record $23.9 billion. Revenue grew 3.5% organically to $5.3 billion, driven by Advanced Imaging Solutions and Pharmaceutical Diagnostics, which posted organic growth of 5% and 14.6% respectively. Patient Care Solutions remained weak, with revenue falling 13.5% due to component shortages and fulfilment problems. Management is reviewing strategic options for the segment, including a potential sale. The company maintained its full-year outlook of 3–4% organic sales growth, adjusted earnings per share of $4.80–$5.00, and approximately $1.6 billion in free cash flow. CFO Jay Saccaro is departing, with George Newcomb serving as interim CFO.